Eandi, . M. (2006) “Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer”, Farmeconomia. Health economics and therapeutic pathways, 7(2), pp. 97–117. doi: 10.7175/fe.v7i2.680.